Precision RNA interference of Smad3 and Runx2 via dual targeting nanocarriers mitigates aortic valve disease
Abstract Background Calcific aortic valve disease (CAVD) is a common malady with few treatment options other than valve replacement by surgery or transcatheter aortic valve implantation (TAVI). Endothelial-to-mesenchymal transition (EndMT) of valvular endothelial cells and osteogenic differentiation...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2026-01-01
|
| Reeks: | Journal of Translational Medicine |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12967-026-07686-1 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|